---
title: "Thyroid Cancer"
description: "ENT notes on Thyroid Cancer - Classification, Risk factors, Staging, Investigations and Treatment."
source: "The ENT Resident"
author: "Dr. Mausumi Das"
canonical_url: "https://www.theentresident.com/ent-notes-lectures/thyroid-cancer-causes-symptoms-staging"
categories: ["Thyroid"]
video: "https://www.youtube.com/watch?v=0m14Iq_gzYg"
image: "https://media.theentresident.com/og-images/thyroid-cancer-causes-symptoms-staging.png"
---

# Thyroid Cancer

ENT notes on Thyroid Cancer - Classification, Risk factors, Staging, Investigations and Treatment. Watch the full video lecture on YouTube: https://www.youtube.com/watch?v=0m14Iq_gzYg

## 🦋 Thyroid Cancer – Classification, Risk Factors, Staging, Investigations & Treatment

**Thyroid cancer** accounts for about **1% of all cancers in the body** and has a higher incidence in females.  

- **Sex ratio:** Female : Male = **3 : 1**  

- **Peak incidence:** 3rd–4th decades of life  

---

### 📑 Classification of Thyroid Tumors

**1. WHO Classification (comprehensive list):**
- Follicular adenoma  
- Hyalinizing trabecular tumor  
- Other encapsulated follicular pattern thyroid tumors  
- Papillary thyroid carcinoma  
- Follicular thyroid carcinoma  
- Hürthle cell tumor  
- Poorly differentiated thyroid carcinoma  
- Anaplastic carcinoma  
- Squamous cell carcinoma  
- Medullary thyroid carcinoma  
- Mixed medullary + follicular carcinoma  
- Mucoepidermoid carcinoma (± with eosinophilia)  
- Mucinous carcinoma  
- Ectopic thymoma  
- Spindle epithelial tumor  
- Intrathyroid thymic carcinoma  
- Paraganglioma  
- Mesenchymal stromal tumors  
- Hematolymphoid tumors  
- Germ cell tumors  
- Secondary tumors  

**2. Simplified Classification:**

- **Benign:** Follicular adenoma, Hürthle cell adenoma, microfollicular adenoma, embryonal adenoma  

- **Malignant:**

a. **Primary:**  
- From **follicular epithelium**:  
    - Papillary carcinoma 
    - Follicular carcinoma 
    - Anaplastic carcinoma   

- From **parafollicular C cells**: Medullary carcinoma

- From **lymphoid tissue**: Lymphoma  

b. **Secondary:**  

- **Metastasis** (kidney, lung, colon, breast)  

- **Direct spread** (larynx, post-cricoid carcinoma)  

>What is the most common Benign thyroid tumor?

>What is the most common malignant thyroid tumor?

---

### ⚠️ Risk Factors for Thyroid Cancer

- **Age:** 30–40 years most common; >65 yrs → risk of anaplastic carcinoma  
- **Sex:** Females > males  
- **Family history** Gardner syndrome, Cowden syndrome  
- **Genetic:**  
  - Medullary carcinoma → MEN2A, MEN2B 
  - Papillary carcinoma → Gardner & Cowden syndromes  
- **Radiation exposure:** Strongest risk factor
- **Other risks:** Endemic goiter, Graves’ disease, inborn errors of metabolism  

>What are the features of MEN2A and MEN2B syndrome?

>What are the mutations associated with Papillary, Follicular and Medullary Thyroid Cancer?
---

### 🩺 Clinical Features of Thyroid Cancer

- **Thyroid nodule:**  
  - Usually **painless**  
  - Hard, fixed  
  - Solitary or multiple  

>What are red flag signs in Thyroid nodule that point towards malignancy? 

- **Other features:**  
  - **Cervical lymphadenopathy** 
  - **Pressure symptoms:**  
    - Hoarseness (RLN involvement)  
    - Dysphagia (esophagus compression)  
    - Dyspnea (tracheal compression)  
  - **Horner’s syndrome:** Miosis, ptosis, anhidrosis (sympathetic chain compression)  
  - **Constitutional:** Weight loss, fatigue, fever, night sweats  
  - Rapidly enlarging pre-existing goiter  

---

### 🧾 TNM Staging of Thyroid Cancer

**T Staging:**  
- **T1:** ≤2 cm, confined to thyroid  
  - T1a: ≤1 cm  
  - T1b: >1–2 cm  
- **T2:** >2–4 cm, confined to thyroid  
- **T3:**  
  - T3a: >4 cm confined to thyroid  
  - T3b: any size with extrathyroid extension to strap muscles  
- **T4:** Gross extrathyroid extension  
  - T4a: Invades subcutaneous tissue, larynx, trachea, esophagus, RLN  
  - T4b: Invades prevertebral fascia, mediastinal vessels, carotid artery  

**N Staging:**  
- **Nx:** Cannot assess  
- **N0:** No Lymph Node involvement  
- **N1a:** Level VI (pretracheal, paratracheal, prelaryngeal, superior mediastinal)  
- **N1b:** Unilateral, bilateral, or contralateral cervical Lymph Nodes (levels I–V) or retropharyngeal Lymph Nodes  

**M Staging:**  
- **M0:** No distant metastasis  
- **M1:** Distant metastasis present  

**Residual Tumor Status:**  
- **R0:** No residual tumor  
- **R1:** Microscopic residual  
- **R2:** Macroscopic residual

---

### 🎯 Stage Grouping

**Medullary Thyroid Carcinoma:**  
- Stage I: T1a/b, N0  
- Stage II: T2/T3, N0  
- Stage III: T1–T3, N1a  
- Stage IVA: T1–T3, N1b or T4a  
- Stage IVB: T4b  
- Stage IVC: Any T, Any N, M1  

**Papillary & Follicular Carcinoma:**  

**< 55 years:**  
- Stage I: Any T, Any N, M0  
- Stage II: Any T, Any N, M1

**≥ 55 years:**  
- Stage I: T1–T2, N0  
- Stage II: T1–T3, N1 or T3 N0  
- Stage III: T4a  
- Stage IVA: T4b  
- Stage IVB: Any M1  

---

### 🧪 Investigations in Thyroid Cancer

- **Blood tests:**  
  - ESR ↑  
  - Thyroid function tests (T3, T4, TSH)  
  - Anti-thyroid antibodies 
  - Serum thyroglobulin 
  - Serum calcitonin 

>Which is the biochemical marker of medullary thyroid cancer?

- **Imaging:**  
  - **Ultrasound (first-line)** 

>What are the suspicious features in ultrasound suggesting thyroid malignancy?

  - **FNAC (gold standard):** Except follicular carcinoma (can’t differentiate adenoma vs carcinoma) → use Bethesda system  

  - **CT/MRI:** Extent, cartilage invasion, retrosternal spread, lymph node assessment  

  - **CT Abdomen:** If lymphoma suspected or MEN syndrome evaluation 

  - **Thyroid scintigraphy:**  
    - Tc-99m scan → Cold nodule (20% risk of malignancy) vs Hot nodule (unlikely malignant)  
    - MIBG scan → MEN syndrome (pheochromocytoma + medullary carcinoma)  
    - Gallium citrate → Thyroid lymphoma  
    - I-131 scan → Post-surgical ablation  

- **Special tests:**  
  - Serum calcitonin + CEA (medullary carcinoma)  
  - RET mutation analysis (MEN syndrome)  
  - Core biopsy (anaplastic carcinoma)  
  - Laryngoscopy (pre-op baseline RLN function)  

---

### 💊 Treatment of Thyroid Cancer

**1. Surgery (Primary Treatment):**  

- **Thyroidectomy types:**  
  - Hemithyroidectomy (1 lobe + isthmus)  
  - Subtotal thyroidectomy (>50% both lobes + isthmus)  
  - Near-total thyroidectomy (1 complete lobe + isthmus + >90% opposite lobe)  
  - Total thyroidectomy (both lobes + isthmus)  
  - Completion thyroidectomy (convert lesser operation to total)  

- **Neck Dissection:** If nodal involvement present  

**2. Radioiodine Ablation (I-131):**  

- For residual tissue/microscopic disease  

>What is the indication of Radioiodine ablation in Thyroid malignancy?

**3. External Beam Radiotherapy (EBRT):**  
- Unresectable tumors  
- Residual disease not responsive to I-131  
- Palliative (bone/brain mets)  

**4. Thyroid Hormone Suppression Therapy:**  
- Levothyroxine to suppress TSH  
- High risk → TSH < 0.1 mIU/L  
- Low risk → TSH 0.1–0.5 mIU/L  

**5. Chemotherapy:**  
- Limited role

---

## About This Note

This free ENT note on Thyroid Cancer was written by Dr. Mausumi Das and is paired with a corresponding video lecture.

Canonical page of this note: https://www.theentresident.com/ent-notes-lectures/thyroid-cancer-causes-symptoms-staging

When citing or referencing this content, please credit The ENT Resident and link to the canonical page above.

## Related Notes by Category

- Thyroid: https://www.theentresident.com/ent-notes-lectures/category/thyroid.md

## About The ENT Resident

The ENT Resident is an educational website and resource library created by Dr. Mausumi Das (MS ENT) for ENT residents, ENT postgraduates preparing for exams, and MBBS students.

Dr. Mausumi Das writes the notes, draws the diagrams, and records the lectures herself.

Browse all ENT notes and lectures on The ENT Resident: https://www.theentresident.com/ent-notes-lectures.md

## Medical-use Boundary

The ENT Resident provides educational material for medical learning and revision. It does not provide patient-specific medical advice, diagnosis, or emergency care, and it is not a substitute for evaluation by a qualified healthcare professional.

## More Resources

- Learn about the Premium ENT Notes, preview a complete sample, and find purchase options: https://www.theentresident.com/premium.md
- Premium note for this topic, Thyroid Cancer: https://theentresident.gumroad.com/l/kgbexd
- Read student testimonials: https://www.theentresident.com/testimonials.md
- Contact The ENT Resident: https://www.theentresident.com/contact.md

---

A complete index of all pages on this site, with descriptions and markdown links can be found here: https://www.theentresident.com/llms.txt
